Utama › Kanser Orofaring
Kajian klinikal Kanser Orofaring sedang mengambil peserta di AS
52 kajian untuk Kanser Orofaring sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Edison, NJ8 kajian
- Atlanta, GA8 kajian
- Chicago, IL7 kajian
- New York City, NY6 kajian
- Queens, NY5 kajian
- Pittsburgh, PA5 kajian
- Milwaukee, WI5 kajian
- Omaha, NE5 kajian
- Philadelphia, PA5 kajian
- Kansas City, MO5 kajian
- Los Angeles, CA5 kajian
- St. Louis, MO5 kajian
- Houston, TX5 kajian
- Tampa, FL5 kajian
- Rochester, MN4 kajian
- East Norwalk, CT4 kajian
- Greenburgh, NY4 kajian
- Staten Island, NY4 kajian
- Kansas City, KS4 kajian
- Naperville, IL4 kajian
- Detroit, MI4 kajian
- Ann Arbor, MI4 kajian
- Durham, NC4 kajian
- Overland Park, KS4 kajian
- Washington, DC4 kajian
- Richmond, VA4 kajian
- Baltimore, MD4 kajian
- New Rochelle, NY3 kajian
- West Bend, WI3 kajian
- Oklahoma City, OK3 kajian
- Champaign, IL3 kajian
- Charleston, IL3 kajian
- Des Moines, IA3 kajian
- Danville, IL3 kajian
- Portland, OR3 kajian
- Stevens Point, WI3 kajian
- Joliet, IL3 kajian
- Peoria, IL3 kajian
- Bloomington, IL3 kajian
- Wausau, WI3 kajian
Mengikut negeri
- Arizona4 kajian
- California9 kajian
- Colorado4 kajian
- Florida12 kajian
- Georgia8 kajian
- Illinois8 kajian
- Iowa5 kajian
- Kansas5 kajian
- Kentucky3 kajian
- Maryland7 kajian
- Massachusetts4 kajian
- Michigan6 kajian
- Minnesota6 kajian
- Missouri9 kajian
- Nebraska5 kajian
- New Hampshire3 kajian
- New Jersey8 kajian
- New York11 kajian
- North Carolina6 kajian
- North Dakota3 kajian
- Ohio8 kajian
- Oklahoma4 kajian
- Oregon3 kajian
- Pennsylvania10 kajian
- South Carolina3 kajian
- Tennessee3 kajian
- Texas6 kajian
- Vermont3 kajian
- Virginia4 kajian
- Wilayah Columbia3 kajian
- Wisconsin6 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05541016Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07195734Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly
Mengambil peserta
Umur 65 hingga 99 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06309225BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05136196Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06305676Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05172245Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05880797Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT07441681Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
Mengambil pesertaFasa 2
Umur 22 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT04900623Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06254911Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06445114Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT04198766The Minimalist Trial-2
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT06702033Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Jul 2026 · NCT05388773Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06662058pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT05799144Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT01365169Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT07178301SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT05451004Integrated Cancer Repository for Cancer Research
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Jun 2026 · NCT04151082E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jun 2026 · NCT05686226Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.